Solanbridge Group, Inc. (SLNX) Research

Solanbridge Group, Inc. concentrates its efforts on cultivating and marketing medical cannabis in Nova Scotia, Canada. Additionally, the organization is committed to developing and distributing a range of CBD-enriched products throughout Nevada, California, and Colorado. The enterprise was founded in 2000 and maintains its main corporate offices in The Woodlands, Texas.

Market snapshot

Symbol
SLNX
Price
$0.00
Day change
0.00%
Market cap
$476.0K
P/E ratio
-7.14x
52-week range
0.000001-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Dakshidin Corporation, Inc. (DKSC)
  • American Green, Inc. (ERBB)
  • Creative Edge Nutrition, Inc. (FITX)
  • For The Earth Corp. (FTEG)
  • Radiko Holdings Corp. (GEATF)
  • Global Roundtable Corporation (GRCU)
  • Gold River Productions, Inc. (GRPS)
  • Stemtech Corporation (STEK)

Open Solanbridge Group, Inc. (SLNX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.